CureVac
CureVac is a global biopharmaceutical company developing a new class of medicines based on messenger ribonucleic acid (mRNA).
/10
Transparency ranking
Work at CureVac?
Show us we're wrong
Description
CureVac is a global biopharmaceutical company that specializes in the development of messenger ribonucleic acid (mRNA) based therapies. Founded in 2000, the company has pioneered the use of mRNA as a therapeutic agent and has a wide-ranging pipeline of mRNA-based candidates in prophylactic vaccines, oncology and molecular therapy. CureVac has a proven track record of innovation in the mRNA space, having been instrumental in the development of mRNA vaccines against COVID-19. The company is dedicated to revolutionizing medicine and improving human life through its cutting-edge mRNA technology.
CureVac's research and development focuses on creating new drugs and treatments by using the body's natural processes to fight disease. Their mRNA technology allows for the development of highly targeted and personalized therapies, offering potential for safer and more effective treatments. CureVac is committed to working with partners, such as other pharmaceutical companies and global health organizations, to ensure the widespread availability of its innovative therapies to those who need them.
Flexibility
CureVac offers flexible work arrangements, though specific details aren't mentioned in the provided job posting. The company emphasizes its commitment to creating an attractive workplace for employees who want to contribute to their mission of improving patients' lives, suggesting a culture that values employee well-being and potentially accommodates individual needs.
Mission
CureVac is a biopharmaceutical company dedicated to developing a new class of drugs based on messenger RNA (mRNA). Their mission is to revolutionize medicine by creating safe and effective mRNA-based therapeutics to protect and improve human lives. Driven by their proprietary technology platform and decades of scientific expertise, they strive to develop vaccines, cancer immunotherapies, and molecular therapies that enable the body to produce its own disease-fighting agents.
Culture
CureVac promotes a culture of innovation, collaboration, and patient focus. The company emphasizes a team-oriented approach and encourages open communication and a willingness to embrace new ideas. They value responsibility and respect for employees and patients, striving to create a workplace where individuals can thrive and contribute to a medical revolution.
DE&I
CureVac promotes a culture of diversity, equity, and inclusion, recognizing the importance of a diverse workforce for innovation and success. They value respect, trust, and collaboration across different backgrounds and perspectives. The company strives to create an inclusive environment where all employees feel valued, supported, and empowered to contribute their unique talents and ideas.